Hinova Pharmaceuticals Inc. A Net Asset Quality Index
Hinova Pharmaceuticals Inc. A net asset quality index. Hinova Pharmaceuticals Inc. A (688302) has a Net Asset Quality Index of 81.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.39 Billion minus total liabilities of CN¥255.12 Million yields net assets of CN¥1.14 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Hinova Pharmaceuticals Inc. A (688302) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Hinova Pharmaceuticals Inc. A (2019–2024)
Net asset quality index of Hinova Pharmaceuticals Inc. A from 2019 to 2024. This chart shows how Hinova Pharmaceuticals Inc. A's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 81.7%, representing net assets of CN¥1.14 Billion against total assets of CN¥1.39 Billion CNY. Check 688302 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Hinova Pharmaceuticals Inc. A Net Asset Quality Index by Year (2019–2024)
Hinova Pharmaceuticals Inc. A net asset quality index by year from 2019 to 2024. The table below presents the year-by-year Net Asset Quality Index for Hinova Pharmaceuticals Inc. A from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hinova Pharmaceuticals Inc. A market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.6% | CN¥1.19 Billion | CN¥1.36 Billion | CN¥169.33 Million | ▼ -4.1 pp |
| 2023 | 91.7% | CN¥1.37 Billion | CN¥1.49 Billion | CN¥124.47 Million | ▲ +0.3 pp |
| 2022 | 91.4% | CN¥1.59 Billion | CN¥1.74 Billion | CN¥149.68 Million | ▲ +11.1 pp |
| 2021 | 80.3% | CN¥788.76 Million | CN¥982.35 Million | CN¥193.59 Million | ▼ -2.7 pp |
| 2020 | 83.0% | CN¥986.15 Million | CN¥1.19 Billion | CN¥202.33 Million | ▲ +163.0 pp |
| 2019 | -80.0% | CN¥-35.78 Million | CN¥44.72 Million | CN¥80.50 Million | — |